{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:27:30Z","timestamp":1790447250506,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/sap.0b013e3181828141","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T12:07:59Z","timestamp":1242907679000},"page":"707-709","source":"Crossref","is-referenced-by-count":152,"title":["A Review on Bevacizumab and Surgical Wound Healing"],"prefix":"10.1097","volume":"62","author":[{"given":"Chad R.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Rojavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Zins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Generosa","family":"Grana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Atabek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20210202","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.tp.0000229429.05420.3a","article-title":"Vascular endothelial growth factor: the good, the bad, and the ugly.","volume":"82","author":"Uhlmann","year":"2006","journal-title":"Transplantation"},{"key":"R2-30-20210202","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.cco.0000228734.32261.62","article-title":"Adverse effects of the humanized antibodies used as cancer therapeutics.","volume":"18","author":"Klastersky","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"R3-30-20210202","doi-asserted-by":"crossref","first-page":"53","DOI":"10.6004\/jnccn.2008.0006","article-title":"Chemotherapy for advanced, recurrent, and metastatic cervical cancer.","volume":"6","author":"Moore","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"R4-30-20210202","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/PPO.0b013e318161c014","article-title":"The role of angiogenesis inhibitors in prostate cancer.","volume":"14","author":"Aragon-Ching","year":"2008","journal-title":"Cancer J"},{"key":"R5-30-20210202","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2007.11.5345","article-title":"Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.","volume":"25","author":"Burger","year":"2007","journal-title":"J Clin Oncol"},{"key":"R8-30-20210202","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications.","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"R9-30-20210202","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00129334-200511000-00013","article-title":"The role of therapeutic angiogenesis in tissue repair and regeneration.","volume":"18","author":"Li","year":"2005","journal-title":"Adv Skin Wound Care"},{"key":"R10-30-20210202","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.biocel.2007.04.010","article-title":"Vascular endothelial growth factor; biology and therapeutic applications.","volume":"39","author":"Ho","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"R11-30-20210202","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/01.cco.0000183672.15133.ab","article-title":"Update on angiogenesis inhibitors.","volume":"17","author":"Zakarija","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"R13-30-20210202","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1200\/JCO.2003.10.066","article-title":"Phase II, randomized trial comparing bevacizumab plus flurouracil (FU)\/leucovorin(LV) with FU\/LV alone in patients with metastatic colorectal cancer.","volume":"21","author":"Kabbinavar","year":"2003","journal-title":"J Clin Oncol"},{"key":"R14-30-20210202","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/jnci\/djm086","article-title":"Arterial thrombo-embolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.","volume":"99","author":"Scappaticci","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R15-30-20210202","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1200\/JCO.2005.23.754","article-title":"Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.","volume":"23","author":"Ellis","year":"2005","journal-title":"J Clin Oncol"},{"key":"R16-30-20210202","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovarin for metastatic colorectal cancer.","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"R17-30-20210202","article-title":"Avastin [package insert]."},{"key":"R18-30-20210202","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1245\/s10434-006-9074-0","article-title":"Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of Bevacizumab: a matched case-control study.","volume":"14","author":"D'Angelica","year":"2007","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000637-200906000-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:56:21Z","timestamp":1786038981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000637-200906000-00030"}},"subtitle":["An Important Warning to All Surgeons"],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0b013e3181828141","relation":{},"ISSN":["0148-7043"],"issn-type":[{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}